Immunotherapy post-surgery improves overall survival for kidney cancer: Study finds
For the first time in 50 years, a phase 3 randomised, placebo-controlled trial found that an adjuvant therapy improved overall survival in kidney cancer patients. Treating patients with clear-cell renal-cell carcinoma (ccRCC) at high risk for recurrence …